Business Wire

Mercans Launches G2N Nova: Its Latest Gross-to-Net Multi-country Payroll Engine

25.7.2023 21:28:00 CEST | Business Wire | Press Release

Share

Mercans, global payroll technology leader, has introduced its groundbreaking third-generation software, G2N Nova. The latest version of Mercans’ disruptive payroll platform enhances global gross-to-net payroll calculation capabilities and introduces new features that enable multinationals to consolidate and digitalize their international payroll processes.

Mercans' innovative payroll technology challenges the traditional global outsourcing model that is heavily reliant on in-country payroll providers (ICPs) and third-party software solutions. G2N Nova, purpose-built for global payroll, leverages cutting-edge innovations like Machine learning, RPA, Data lakes, Unstructured data management, and digital datafication.

While the traditional legacy payroll software solutions are unable to support multiple countries on a single version, Mercans' horizontal payroll engine architecture reuses the commonalities between payroll calculations across the globe and addresses country-specific regulations through an easily configurable compliance module. This allows G2N Nova to generate statutory-compliant gross-to-net calculations across 100+ countries on a single software instance and in a multi-tenant environment, significantly increasing the accuracy of the tax configurations and payroll calculations.

"Our strategic focus is on SaaS and payroll technology, particularly in the realm of gross-to-net payroll capabilities in a multi-country setting," explains K A Vishwanathan (Vish), CEO of Mercans Payroll & SaaS business.

G2N Nova introduces Complex Event Recognition technology that analyzes data from Human Capital Management (HCM) systems and automatically identifies payroll-relevant events, making the implementation of integrations between G2N Nova and HCM systems more than 5 times faster and reducing the need for any manual intervention by at least 20 times.

"Our objective is to transform the payroll industry from a services-based model to a technology-driven one," affirms Vish. "We envision a fully digital payroll experience that revolutionizes how organizations manage their payroll processes globally. G2N Nova is a significant step towards realizing this vision."

G2N Nova also includes Supernova Payment Gateway module that enables global payroll payments to be routed through any number of financial institutions and payment channels.

Unlike the payment solution offered by other providers, Mercans’ Supernova Payment Gateway does not rely on a single payment channel but routes payments through tens of channels concurrently, creating a virtual payment Super Optimizer. Supernova analyzes each payment instruction, its source and target currencies, initiator and beneficiary, processing fees, and execution time to determine the most optimal routing for each payment instruction. Supernova reduces international banking fees by at least 3 times and the average payment processing time by more than 2 times.

Mercans' Gross to Net Payroll Engine integrates seamlessly with all major HCM systems, providing organizations with a seamless and owned solution for gross-to-net calculations. The addition of an Application Programming Interface (API) specifically for payroll-related data further optimizes the integration process and simplifies payroll processing workflows.

Bottom Line:

The release of G2N Nova marks a significant milestone in Mercans' journey of excellence. Mercans continues to transform the way organizations manage their payroll processes worldwide by combining cutting-edge technology, global best practices, and a customer-centric approach.

Note: The shortened press release highlights key points about G2N Nova and its impact on the global payroll industry. However, for a comprehensive understanding, it's recommended to refer to the original press release for additional details.

About Mercans

Mercans is a global leader in payroll technology. Mercans’ revolutionary global payroll platform HR Blizz enables SMBs & Enterprise businesses to manage payrolls across 160 countries. With 20 years of global payroll expertise, Mercans delivers the full spectrum of HR services through a single, secure global platform.

Visit www.mercans.com

LinkedIn

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mohsin Khan
hello@mercans.com
Berkeley Square House, 2nd Floor, Berkeley Square, London, UK.

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye